- Vouliez-vous dire
- guidelines
Résultats de la recherche - 28 results
A decalogue of Molecular Tumor Board (MTB) recommendations from the CAN.HEAL Consortium
across 17 EU countries, has developed a set of recommendations for Molecular Tumor Boards (MTB s) to address the lack of standardized guidelines in personalized cancer medicine. Health Topics: Cancer ...
Unlocking the genomic landscape: Results of the Beyond 1 Million Genomes (B1MG) pilot in Belgium towards Genomic Data Infrastructure (GDI)
awareness and acceptance; V. Workforce skills and organisation; VI. Clinical organisation, infrastructure and tools; VII. Clinical genomics guidelines and infrastructure; and VIII. Data management, standards ...
Protocol for a systematic review and meta-analysis of the diagnostic test accuracy of host and HPV DNA methylation in cervical cancer screening and management.
methylation cut-off thresholds, and accuracy in high-risk HPV positive women. Our reference standard will be histology. We will perform meta-analyses using Cochrane guidelines for diagnostic test accuracy. We ...
The European response to the WHO call cervical cancer as a public health problem
a group of experts to develop the third edition of European Guidelines for Quality Assurance of Cervical Cancer prevention based on integrated HPV vaccination and screening and to monitor the progress ...
Tackling cervical cancer in Europe amidst the COVID-19 pandemic.
guidelines, and translate them into quantified and monitored preventive activities. However, in the first half of 2020, due to the dramatic COVID-19 pandemic, cervical cancer prevention activities have been ...
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 2 on Triage, Treatment and Follow-up.
neoplasia (CIN) cervical precancerous condition HPV Abstract: EN AIMS Annual opportunistic screening for cervical carcinoma has been done in Germany since 1971. The creation of this S3 guideline meets an ...
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia.
neoplasia (CIN) cervical precancerous condition HPV Abstract: AIMS Annual opportunistic screening for cervical carcinoma has been carried out in Germany since 1971. The creation of this S3 guideline meets an ...
Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.
Guidelines as Topic Reproducibility of Results Sensitivity and Specificity Uterine Cervical Neoplasms Abstract: BACKGROUND Cervical cancer screening with assays detecting DNA of high-risk human papillomavirus ...
Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
studies DNA, Viral Early Detection of Cancer Female Humans Luxembourg middle aged Neoplasm Grading Papillomaviridae Papillomavirus Infections Practice Guidelines as Topic Pregnancy prevalence Squamous ...
Clinical and analytical performance of the PapilloCheck HPV-Screening assay using the VALGENT framework.
of HPV testing for cervical cancer screening and disease management has been shown in many recent studies and is part of several new evidence-based guidelines. Assessment of emerging HPV tests in this ...